|
1) Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-7
|
|
|
|
2) Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a ran-domised controlled trial. Lancet. 2002; 360: 427-35
|
|
|
|
|
3) Rehman, Jingling Li, Christie M, et al. Peripheral blood “endothelial progenitor cells" are derived from monocyte/macrophages and secrete angio-genic growth factors. Circulation. 2003; 107: 1164-9
|
|
|
|
|
|
4) Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis. 2010; 209: 10-7
|
|
|
|
|
|
5) Walter DH, Krankenberg H, Balzer JO, et al. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv. 2011; 4: 26-37
|
|
|
|
|
|
6) Amann B, Ludemann C, Buckert R, et al. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI). VASA. 2008; 37: 319-25
|
|
|
|
|
|
7) Matoba S, Tatsumi T, Murohara T, et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplan-tation [TACT] trial) in patients with chronic limb ischemia. Am Heart J. 2008; 156: 1010-8
|
|
|
|
|
|
8) Miyamamoto K, Nishigami K, Nagaya N, et al. Unblinded pilot study of autologous transplan-tation of bone marrow mononuclear cells in patients with thromboangitis obliterans. Circulation. 2006; 114: 2679-84
|
|
|
|
|
|
9) Idei N, Soga J, Hata T, et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia. Circ Cardiovasc Interv. 2011; 4: 15-25
|
|
|
|
|
|
10) Gupta R, Losordo DW. Cell therapy for critical limb ischemia - Moving forward one step at a time. Circ Cardiovasc Interv. 2011; 4: 2-5
|
|
|
|
|
|
11) Franz RW, Parks A, Shah KJ, et al. Use of autologous bone marrow mononuclear cell implan-tation therapy as a limb salvage procedure in pati-ents with severe peripheral arterial disease. J Vasc Surg. 2009; 50: 1378-90
|
|
|
|
|